This is a prospective, open-label, multi-center, non-comparative study that will be conducted on female subjects between 30 and 75 years of age, diagnosed with stress urinary incontinence (SUI). Following the screening period, including urodynamic assessment to confirm SUI, each subject will undergo three FemiLiftTM treatment sessions, and will be followed up for a period of one year. The main efficacy endpoint in this study is defined as significant improvement (score of 6 or 7) in the urinary incontinence measured with PGI-I score at the 6 months visit. Various subjective and objective measures of incontinence severity, quality of life, sexual function and tissue effects will be performed at follow up.
Improvement in SUI symptoms as measured by the following parameters: Objective parameters: * Change from baseline in 3 days Urinary Diary - at 1, 2, 6 and 12 months: * Number of incontinence episodes per day * Number of pads used per day * Change from baseline in 1 hour pad test 1, 2, 6 and 12 months * Change from baseline as assessed with Vaginal Biopsy Subjective parameters: * Patient Global Impression of Severity (PGI-S) - 4-point Likert scale - at screening, 1, 2, 6 and 12 months * Change from baseline in Pelvic Floor Distress Inventory Questionnaire (PFDI) - at 1, 2, 6 and 12 months * Change from baseline in Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ) - at 1, 2, 6 and 12 months * Change from baseline in Pelvic Floor Impact Questionnaire (PFIQ) - at 1, 2, 6 and 12 months
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
60
The vaginal handpiece sheath is lubricated with baby oil. Set the initial energy level (startup set up recommendations: High mode, 40 millijoule/pixel; according to the patient reaction you can increase up to 120 max. Pulse mode or Repeat mode). The handpiece is inserted as distally as possible, with the laser energy's window oriented to the 12:00 o'clock position. There are position markings on the handpiece. Trigger a laser pulse by pressing the footswitch. Shoot the laser and rotate the probe by one hour at a time. When you reach the 12:00 o'clock position again, withdrawal the headpiece back by one centimeter and repeat the rotational treatment process.
Success Rate - SUI Symptom Improvement
Success rate - defined as an improvement in SUI symptoms as a score or 6 or 7 measured by the Patient Global Impression of Improvement (PGI-I) - 7-point Likert scale - at the 6 months visit
Time frame: 6 months
Urinary Diary
Change from baseline in 3 days Urinary Diary - at 1, 2, 6 and 12 months post first treatment: * Number of incontinence episodes per day
Time frame: 12 months
1 hour pad test
Change from baseline in 1 hour pad test at 1, 2, 6 and 12 months post first treatment
Time frame: 12 months
Vaginal Biopsy
Sample will be obtained from the vaginal mucosa 2 cm inside the introitus on the lateral vaginal wall.
Time frame: 12 months
PGI-S
Change from baseline in Patient Global Impression of Severity (PGI-S) over time
Time frame: 12 months
PFDI
Change from baseline in Pelvic Floor Distress Inventory Questionnaire (PFDI) over time
Time frame: 12 months
PISQ
Change from baseline in Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ) over time
Time frame: 12 months
PFIQ
Change from baseline in Pelvic Floor Impact Questionnaire (PFIQ) over time
Time frame: 12 months
Safety Endpoint assessed by the rate of serious device related adverse events
The rate of serious device related adverse events reported during the study
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.